Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Reduced dark-adaptation: an indication of lithium's neuronal action in humans.

Emrich HM, Zihl J, Raptis C, Wendl A.

Am J Psychiatry. 1990 May;147(5):629-31.

PMID:
2327491
2.
3.

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.

Ikonomov OC, Manji HK.

Am J Psychiatry. 1999 Oct;156(10):1506-14. Review.

PMID:
10518159
4.

The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.

Grof P, Alda M, Grof E, Fox D, Cameron P.

Br J Psychiatry Suppl. 1993 Sep;(21):16-9. Review.

PMID:
8217062
5.

[Importance of calcium ions and calcium antagonists in affective psychoses].

Walden J, Grunze H, Olbrich H, Berger M.

Fortschr Neurol Psychiatr. 1992 Dec;60(12):471-6. Review. German.

PMID:
1337539
6.

Glycine: a possible role in lithium's action and affective illness.

Deutsch SI, Stanley M, Peselow ED, Banay-Schwartz M.

Neuropsychobiology. 1983;9(4):215-8. Review.

PMID:
6358939
7.

Signal transduction pathways. Molecular targets for lithium's actions.

Manji HK, Potter WZ, Lenox RH.

Arch Gen Psychiatry. 1995 Jul;52(7):531-43. Review.

PMID:
7598629
8.

Prophylactic and therapeutic profile of lithium.

Peselow E, Lautin A, Gershon S.

Bibl Psychiatr. 1981;(161):1-31. Review. No abstract available.

PMID:
7023466
9.

New applications of lithium therapy.

Murray JB.

J Psychol. 1990 Jan;124(1):55-73. Review.

PMID:
2108242
10.

The role of the lithium ion in medicine.

Rosenthal NE, Goodwin FK.

Annu Rev Med. 1982;33:555-68. Review. No abstract available.

PMID:
7044279
11.

Responders and non-responders to lithium therapy. Some potential biological indicators.

Mendlewicz J.

Bibl Psychiatr. 1981;(161):63-8. Review. No abstract available.

PMID:
7023469
12.

Lithium and serotonin function: implications for the serotonin hypothesis of depression.

Price LH, Charney DS, Delgado PL, Heninger GR.

Psychopharmacology (Berl). 1990;100(1):3-12. Review.

PMID:
2404294
13.

Has the effectiveness of lithium changed? Impact of the variety of lithium's effects.

Grof P.

Neuropsychopharmacology. 1998 Sep;19(3):183-8. Review.

14.

Inositol, lithium, and the brain.

Agranoff BW, Fisher SK.

Psychopharmacol Bull. 2001 Summer;35(3):5-18. Review.

PMID:
12397875
15.

Lithium and the retina.

Seggie J.

Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(2-3):241-53. Review.

PMID:
3290997
16.

Meta-analysis of the effects of lithium usage on serum creatinine levels.

Paul R, Minay J, Cardwell C, Fogarty D, Kelly C.

J Psychopharmacol. 2010 Oct;24(10):1425-31. doi: 10.1177/0269881109104930. Epub 2009 Apr 24. Review.

PMID:
19395432
17.
18.

Lithium and hematopoiesis.

Barr RD, Galbraith PR.

Can Med Assoc J. 1983 Jan 15;128(2):123-6. Review.

19.

Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency.

Guscott R, Taylor L.

Br J Psychiatry. 1994 Jun;164(6):741-6. Review.

PMID:
7952980
20.

The lithium ion: a foundation for psychopharmacological specificity.

Soares JC, Gershon S.

Neuropsychopharmacology. 1998 Sep;19(3):167-82. Review.

Supplemental Content

Support Center